Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-236107

Chief Development Officer sold 20,000 shares at $89.94 ($1,798,782)

  • Chief Development Officer acquired 20,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Guyer William · Chief Development Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-07 Exercise or conversion : show line 1 in the form 10b5-1 +20,000 $21.65 $433,000 25,287 D
2025-10-07 Sale : show line 2 in the form 10b5-1 −20,000 $89.94 $1,798,782 5,287 D
Open-market sales · 20,000 sh · avg $89.94 · $1,798,782

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-07 Exercise or conversion : show line 3 in the form 10b5-1 Stock option (right to buy) −20,000 310,000 D
Loading xslF345X05/ownership.xml…